Ellen A. Croonen

Ellen A. Croonen

Auto-generated profile, based on publicly available information

Ellen A. Croonen

Department of Pediatrics, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, The Netherlands

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2018 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
ECEllen A. Croonen
Ellen A. Croonen
JDJos M. T. Draaisma
Jos M. T. Draaisma
IBIneke van der Burgt
Ineke van der Burgt
NRNel Roeleveld
Nel Roeleveld
CNCees Noordam
Cees Noordam

19 June 2017 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
ECEllen A. Croonen
Ellen A. Croonen
MEMarlou Essink
Marlou Essink
IBIneke van der Burgt
Ineke van der Burgt
JDJos M. Draaisma
Jos M. Draaisma
Cees NoordamCees Noordam
Cees Noordam
MSMaria W. G. Nijhuis‐Van der Sanden
Maria W. G. Nijhuis‐Van der Sanden

24 June 2016 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
ECEllen A. Croonen
Ellen A. Croonen
MHMirjam Harmsen
Mirjam Harmsen
IBIneke Van der Burgt
Ineke Van der Burgt
JDJos M. Draaisma
Jos M. Draaisma
KNKees Noordam
Kees Noordam
RSRia Nijhuis-van der Sanden
Ria Nijhuis-van der Sanden

20 October 2021 in Journal of Medical Internet Research
Verified
Journal Article
Open access
MOMartinus C Oppelaar
Martinus C Oppelaar
LWLara S van Den Wijngaart
Lara S van Den Wijngaart
PMPeter Merkus
Peter Merkus
ECEllen A Croonen
Ellen A Croonen
CHCindy A C Hugen
Cindy A C Hugen
JRJ Roukema
J Roukema
Background: The COVID-19 pandemic has boosted the use of forced expiratory volume in 1 second (FEV1) telemonitoring in pediatric asthma, but a consensus on its most efficient and effective implementation is still lacking. To find answers, it is important to study how such an intervention is perceived, experienced, and used by both patients and health care professionals (HCPs). Objective: The aim of this study was to provide perspectives on how FEV1 home monitoring should be used in pediatric asthma. Methods: This is a qualitative, multicenter, prospective, observational study which included patients with asthma aged 6-16 and HCPs. Primary outcomes were results of 2 surveys that were sent to all participants at study start and after 3-4 months. Secondary outcomes consisted of FEV1 device usage during 4 months after receiving the FEV1 device. Results: A total of 39 participants (26 patients and 13 HCPs) were included in this study. Survey response rates were 97% (38/39) at the start and 87% (34/39) at the end of the study. Both patients and HCPs were receptive toward online FEV1 home monitoring and found it contributive to asthma control, self-management, and disease perception. The main concerns were about reliability of the FEV1 device and validity of home-performed lung function maneuvers. FEV1 devices were used with a median frequency of 7.5 (IQR 3.3-25.5) during the 4-month study period. Conclusions: Patients and HCPs are receptive toward online FEV1 home monitoring. Frequency of measurements varied largely among individuals, yet perceived benefits remained similar. This emphasizes that online FEV1 home monitoring strategies should be used as a means to reach individual goals, rather than being a goal on their own.

2 December 2025 in Pediatric Pulmonology
Verified
Journal Article
Open access
MOM. C. Oppelaar
M. C. Oppelaar
PKP. J. M. Kleven
P. J. M. Kleven
LNL. E. M. Niers
L. E. M. Niers
ABA. L. M. Boehmer
A. L. M. Boehmer
BEB. E. van Ewijk
B. E. van Ewijk
JRJ Roukema
J Roukema
Introduction: There is need for real‐life, long‐term and large‐scale multicentre studies on remote monitoring (RM) in respiratory care to determine its true potential for daily practice. We aimed to analyze the effect of RM with digital action plans on healthcare utilization in long‐term pediatric asthma care. Methods: This was a cohort study in six Dutch pediatric asthma clinics from 2017 until 2023 using healthcare utilization and RM data. Children aged 6–18 years with ≥ 2 years follow‐up were included. Differences in median number of outpatient visits between the RM and regular care groups were assessed. Incidence rate ratios (IRR) were calculated for emergency visits and hospitalizations. Interrupted time series analysis was used to evaluate changes in number of outpatient visits after introduction of RM over time. Asthma control of children with RM was analyzed over time. Results: We included 2526 children, of which 1372 (54.2%) used RM. The median number of annual outpatient visits was lower in the RM group than in the regular care group (ΔMedian 0.65, p < 0.001). RM was associated with a decreased risk of emergency visits (IRR 0.52; 95% CI 0.44, 0.61) and hospitalizations (IRR 0.43; 95% CI 0.34, 0.55). RM was associated with an annual outpatient visit reduction of −9.4 (95% CI −17.0, −1.9) per 100 children. The proportion of children with controlled asthma increased from 76.7% to 86.0% 3 years after introduction of RM. Conclusions: RM with digital treatment plans is associated with reductions in both regular and emergency healthcare utilization while maintaining high rates of well‐controlled asthma.

30 March 2021 in JMIR Preprints
Verified
Preprint
Open access
MOMartinus C Oppelaar
Martinus C Oppelaar
LWLara S van Den Wijngaart
Lara S van Den Wijngaart
PMPeter Merkus
Peter Merkus
ECEllen A Croonen
Ellen A Croonen
CHCindy A C Hugen
Cindy A C Hugen
JRJ Roukema
J Roukema
BACKGROUND The COVID-19 pandemic has boosted the use of forced expiratory volume in 1 second (FEV1) telemonitoring in pediatric asthma, but a consensus on its most efficient and effective implementation is still lacking. To find answers, it is important to study how such an intervention is perceived, experienced, and used by both patients and health care professionals (HCPs). OBJECTIVE The aim of this study was to provide perspectives on how FEV1 home monitoring should be used in pediatric asthma. METHODS This is a qualitative, multicenter, prospective, observational study which included patients with asthma aged 6-16 and HCPs. Primary outcomes were results of 2 surveys that were sent to all participants at study start and after 3-4 months. Secondary outcomes consisted of FEV1 device usage during 4 months after receiving the FEV1 device. RESULTS A total of 39 participants (26 patients and 13 HCPs) were included in this study. Survey response rates were 97% (38/39) at the start and 87% (34/39) at the end of the study. Both patients and HCPs were receptive toward online FEV1 home monitoring and found it contributive to asthma control, self-management, and disease perception. The main concerns were about reliability of the FEV1 device and validity of home-performed lung function maneuvers. FEV1 devices were used with a median frequency of 7.5 (IQR 3.3-25.5) during the 4-month study period. CONCLUSIONS Patients and HCPs are receptive toward online FEV1 home monitoring. Frequency of measurements varied largely among individuals, yet perceived benefits remained similar. This emphasizes that online FEV1 home monitoring strategies should be used as a means to reach individual goals, rather than being a goal on their own.